The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis-Reference-Cited by-同舟云学术

The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis

Published:2014-11-06 Issue:11 Volume:9 Page:e111651
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Yanlong,Luo Xiuping,Yang Nuo,Feng Ronghao,Xian Lei

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Cancer statistics, 2010;A Jemal;CA Cancer J Clin,2010

2. Global cancer statistics;A Jemal;CA Cancer J Clin,2011

3. Small-cell lung cancer;DM Jackman;Lancet,2005

4. Chemotherapy for small cell lung cancer;AB Sandler;Semin Oncol,2003

5. Multidisciplinary management of lung cancer;A Spira;N Engl J Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer;Pharmaceutics;2024-08-25

2. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report;Japanese Journal of Clinical Oncology;2019-10-15

3. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2017-12

4. Methodological quality evaluation of systematic reviews or meta-analyses on ERCC1 in non-small cell lung cancer: a systematic review;Journal of Cancer Research and Clinical Oncology;2017-09-05

5. Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients;Pharmacogenomics;2016-05